Index Ventures exits X01

According to a blog post on its site, Index Ventures has sold X01 Ltd to Janssen Pharmaceuticals Inc, a Johnson and Johnson subsidiary. No financial terms were disclosed. X01 is a cardiovascular drug startup. To read the announcement, visit here.

Reuters – J&J Looks to Sell to sell US Feminine Hygiene Business

Johnson and Johnson is looking to sell most of its US feminine hygiene business, as it seeks to exit low-growth areas, but wants to keep its K-Y brand, writes Reuters. The diversified healthcare giant wants to unload its Stayfree and Carefree pads and o.b. tampons, according to Reuters.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget